Tumor Necrosis Factor (TNF)-α Secretion by ex Vivo Lipopolysaccharide (LPS)-Stimulated Peripheral Blood Mononuclear Cells (PBMCs) [clinicaltrials_resource:NCT01727895/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Tumor Necrosis Factor (TNF)-α Secretion by ex Vivo Lipopolysaccharide (LPS)-Stimulated Peripheral Blood Mononuclear Cells (PBMCs) [clinicaltrials_resource:NCT01727895/outcome/1]
Bio2RDF identifier
NCT01727895/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT01727895/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
Days 0, 6, 21
days 0, 6, 21
up to 21 days
type [clinicaltrials_vocabulary:type]
alternate
Tumor Necrosis Factor (TNF)-α ...... lood Mononuclear Cells (PBMCs)
@en
identifier
clinicaltrials_resource:NCT01727895/outcome/1
title
The primary objective of the s ...... of the antimicrobial response
@en
type
label
Tumor Necrosis Factor (TNF)-α ...... esource:NCT01727895/outcome/1]
@en